Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Kerbel

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Cancer Research and Treatment|September 12, 2009
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugsRobert S Kerbel
Journal of Mammary Gland Biology and Neoplasia|September 27, 2012
Strategies for improving the clinical benefit of antiangiogenic drug based therapies for breast cancerRobert S Kerbel
Seminars in Oncology|February 26, 2004
Antiangiogenic drugs and current strategies for the treatment of lung cancerRobert S Kerbel
Breast (Edinburgh, Scotland)|November 17, 2009
Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancerRobert S Kerbel
Breast (Edinburgh, Scotland)|October 22, 2011
Reappraising antiangiogenic therapy for breast cancerRobert S Kerbel
Cancer Journal (Sudbury, Mass.)|July 30, 2015
A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor MicroenvironmentRobert S Kerbel
Cancer Cell|October 18, 2005
Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealedRobert S Kerbel
The New England Journal of Medicine|May 9, 2008
Tumor angiogenesisRobert S Kerbel
Cancer Biology & Therapy|April 4, 2003
Some guidelines for building a successful career in cancer researchRobert S Kerbel
Science (New York, N.Y.)|May 27, 2006
Antiangiogenic therapy: a universal chemosensitization strategy for cancer?Robert S Kerbel
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Cancer Research and Treatment|September 12, 2009
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugsRobert S Kerbel
Journal of Mammary Gland Biology and Neoplasia|September 27, 2012
Strategies for improving the clinical benefit of antiangiogenic drug based therapies for breast cancerRobert S Kerbel
Seminars in Oncology|February 26, 2004
Antiangiogenic drugs and current strategies for the treatment of lung cancerRobert S Kerbel
Breast (Edinburgh, Scotland)|November 17, 2009
Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancerRobert S Kerbel
Breast (Edinburgh, Scotland)|October 22, 2011
Reappraising antiangiogenic therapy for breast cancerRobert S Kerbel
Cancer Journal (Sudbury, Mass.)|July 30, 2015
A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor MicroenvironmentRobert S Kerbel
Cancer Cell|October 18, 2005
Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealedRobert S Kerbel
The New England Journal of Medicine|May 9, 2008
Tumor angiogenesisRobert S Kerbel
Cancer Biology & Therapy|April 4, 2003
Some guidelines for building a successful career in cancer researchRobert S Kerbel
Science (New York, N.Y.)|May 27, 2006
Antiangiogenic therapy: a universal chemosensitization strategy for cancer?Robert S Kerbel
Pageof 19